Fleury S.A.
FLRY3
Rank in Stocks
#5793
Fleury S.A., a Brazilian healthcare provider, along with its subsidiaries,... Fleury S.A., a Brazilian healthcare provider, along with its subsidiaries, delivers a broad spectrum of medical services. These offerings span diagnostics, various treatments, clinical analysis, health management, general medical care, orthopedics, and ophthalmology. The company organizes its operations into three primary segments: Diagnostic Medicine, Integrated Medicine, and Dental. Its service portfolio includes laboratory and imaging examinations, comprehensive diagnostic information, health check-ups, specialized reference laboratory functions, genomic testing, day clinic facilities, infusion centers, and dental imaging and radiology. Additionally, Fleury provides Saúde I, a digital health platform that facilitates teleconsultations, remote medical advice, online diagnostic exams, and virtual procedures. It further extends its services to corporate clients with tailored solutions, offers in-person primary care, and supports medical professionals through digital office tools and ongoing medical education. Established in 1926 and headquartered in São Paulo, Brazil, the company operates an extensive network comprising 284 outpatient service centers and 31 hospital-based units, many of which are known under brands like Labs a+, Felippe Mattoso, Lafe, Fleury, a+SP, CIP, Moacir Cunha, Vita, inlab, Weinmann, Serdil, Diagmax, IRN / CPC, Diagnosis a+, a+BA, Pretti, and Bioclinic.
Share Price
$3.80
Last synced: 2026-11-10
Market Cap
$2.07B
Change (1 day)
0.00%
Change (1 year)
26.77%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Fleury S.A. (FLRY3)
Category
Healthcare
EPS for Fleury S.A. (FLRY3)
EPS as of June 2026 TTM: $0.24
According to Fleury S.A.'s latest financial reports, its current EPS (TTM) is $0.24. At the end of 2025 the company had an EPS of $0.20, an increase over its 2024 EPS of $0.18.
EPS history for Fleury S.A. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.24 | 21.55% |
| 2025 | $0.20 | 11.04% |
| 2024 | $0.18 | 2.01% |
| 2023 | $0.18 | 4.18% |
| 2022 | $0.17 | -8.70% |
| 2021 | $0.19 | 28.84% |
| 2020 | $0.15 | -36.75% |
| 2019 | $0.23 | -9.33% |
| 2018 | $0.26 | -12.00% |
| 2017 | $0.29 | 36.68% |
| 2016 | $0.21 | 154.01% |
| 2015 | $0.08 | -14.45% |
| 2014 | $0.10 | 28.08% |
| 2013 | $0.08 | -51.22% |
| 2012 | $0.16 | -16.74% |
| 2011 | $0.19 | -33.73% |
| 2010 | $0.28 | 59.13% |
| 2009 | $0.18 | 158.20% |
| 2008 | $0.07 | 29.03% |
| 2007 | $0.05 | -4.81% |
| 2006 | $0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | 7,711.60% |
US
|
|
| $6.12 | 2,417.48% |
US
|
|
| $1.38 | 466.47% |
CN
|
|
| $14.83 | 6,000.37% |
US
|
|
| $5.09 | 1,993.79% |
US
|
Questions about Fleury S.A.'s earnings per share (EPS)
What is Fleury S.A.'s earnings per share (EPS)?
Fleury S.A.'s earnings per share (EPS) over the last twelve months is $0.24, as of Jun 2026.
What was Fleury S.A.'s earnings per share (EPS) in 2025?
In 2025, Fleury S.A.'s earnings per share (EPS) was $0.20, 11.11% more than in 2024 ($0.18).
How has Fleury S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Fleury S.A.'s earnings per share (EPS) went from $0.15 to $0.20, an average growth of 5.92% a year.
How does Fleury S.A.'s earnings per share (EPS) compare with similar companies?
Fleury S.A.'s earnings per share (EPS) ($0.24) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.